Search results
Dipak Kotecha
Research Area(s) / Expertise:
Job title: Professor of Cardiology & Cardiac Imaging and Consultant Cardiologist
Author
Biological Aging, AI & the Brain-Heart Connection: A Conversation with Dr Valentin Fuster
Added:
1 year ago
Podcast Episode
Dike Bevis Ojji
Author
Prakash Deedwania
Job title: Professor of Medicine
Author
Raif Tawakol
Job title: Director
Author
Author(s):
Marianna Fontana
Added:
1 year ago
AHA Conference 2024 - Safety and efficacy outcomes of nexiguran ziclumeran (NTLA-2001) in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).Dr Marianna Fontana (University College London, London, UK) joins us onsite at AHA Conference to discuss the findings from the nexiguran ziclumeran for ATTR-CM trial (NCT04601051).Dr Fontana discusses a phase 1, ongoing, open-label, single…
View more
Diana Gorog
Research Area(s) / Expertise:
Job title: Cardiologist and Clinical Lead for Non-cancer Research
Author
Added:
6 months ago
Source:
Radcliffe Cardiology
An exploratory analysis of the ODYSSEY-HCM trial has shown that mavacamten significantly reduces key cardiac biomarkers in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), a condition with no approved therapies.¹ While the main trial did not meet its primary endpoints of improving functional capacity or patient-reported health status, these biomarker findings suggest a…
View more
Author(s):
Ahmad Masri
,
Added:
2 years ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive…
View more
Author(s):
Nicolas M Van Mieghem
Added:
7 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for…
View more